{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T04:48:25Z","timestamp":1789447705768,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:00:00Z","timestamp":1729814400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009845","name":"Ovarian Cancer Research Foundation","doi-asserted-by":"publisher","award":["GA-2019-20"],"award-info":[{"award-number":["GA-2019-20"]}],"id":[{"id":"10.13039\/100009845","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004752","name":"State Government of Victoria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004752","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.celrep.2024.114979","type":"journal-article","created":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T16:04:23Z","timestamp":1731513863000},"page":"114979","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Leader cells promote immunosuppression to drive ovarian cancer progression in\u00a0vivo"],"prefix":"10.1016","volume":"43","author":[{"given":"Amy L.","family":"Wilson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura R.","family":"Moffitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany R.","family":"Doran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bashirah","family":"Basri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennie","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W.","family":"Jobling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Plebanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew N.","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maree","family":"Bilandzic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2024.114979_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA. Cancer J. Clin."},{"key":"10.1016\/j.celrep.2024.114979_bib2","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ygyno.2016.11.019","article-title":"Worldwide comparison of\u00a0ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)","volume":"144","author":"Matz","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.celrep.2024.114979_bib3","article-title":"Treatment of epithelial ovarian cancer","volume":"371","author":"Kuroki","year":"2020","journal-title":"Bmj"},{"key":"10.1016\/j.celrep.2024.114979_bib4","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0140-6736(13)62146-7","article-title":"Ovarian cancer","volume":"384","author":"Jayson","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.celrep.2024.114979_bib5","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","article-title":"Epithelial ovarian cancer","volume":"393","author":"Lheureux","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.celrep.2024.114979_bib6","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.trsl.2016.03.016","article-title":"New models of hematogenous ovarian cancer metastasis demonstrate preferential spread to the ovary and a requirement for\u00a0the ovary for abdominal dissemination","volume":"175","author":"Coffman","year":"2016","journal-title":"Transl. Res."},{"key":"10.1016\/j.celrep.2024.114979_bib7","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrc3432","article-title":"Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research","volume":"13","author":"Kipps","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.celrep.2024.114979_bib8","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s10585-008-9171-5","article-title":"Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression","volume":"25","author":"Hudson","year":"2008","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.celrep.2024.114979_bib9","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10555-012-9351-2","article-title":"Cell-cell and cell-matrix dynamics in intraperitoneal cancer metastasis","volume":"31","author":"Sodek","year":"2012","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.celrep.2024.114979_bib10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1158\/1078-0432.113.11.1","article-title":"Peritoneal and subperitoneal stroma may facilitate regional spread of ovarian cancer","volume":"11","author":"Wang","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2024.114979_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20061466","article-title":"Therapeutic Targeting of Collective Invasion in Ovarian Cancer","volume":"20","author":"Moffitt","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.celrep.2024.114979_bib12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrm.2015.14","article-title":"The front and rear of collective cell migration","volume":"17","author":"Mayor","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.celrep.2024.114979_bib13","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1158\/2159-8274.CD-11-0010","article-title":"Ovarian cancer spheroids use myosin-generated force to clear the mesothelium","volume":"1","author":"Iwanicki","year":"2011","journal-title":"Cancer Discov."},{"key":"10.1016\/j.celrep.2024.114979_bib14","article-title":"Cancer Stem Cells: From Historical Roots to a New Perspective","volume":"2019","author":"Capp","year":"2019","journal-title":"J.\u00a0Oncol."},{"key":"10.1016\/j.celrep.2024.114979_bib15","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/pros.22775","article-title":"CD44 variant 6 is associated with prostate cancer metastasis and chemo-\/radioresistance","volume":"74","author":"Ni","year":"2014","journal-title":"Prostate"},{"key":"10.1016\/j.celrep.2024.114979_bib16","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.3390\/cancers11091228","article-title":"Keratin-14 (KRT14) Positive Leader Cells Mediate Mesothelial Clearance and Invasion by Ovarian Cancer Cells","volume":"11","author":"Bilandzic","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.celrep.2024.114979_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1365-2559.2001.01105.x","article-title":"Cytokeratin 14 expression in epithelial neoplasms: a survey of 435 cases with emphasis on its value\u00a0in\u00a0differentiating squamous cell carcinomas from other epithelial tumours","volume":"39","author":"Chu","year":"2001","journal-title":"Histopathology"},{"key":"10.1016\/j.celrep.2024.114979_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11914","article-title":"KRT14 marks a subpopulation of bladder basal cells with pivotal role in regeneration and tumorigenesis","volume":"7","author":"Papafotiou","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2024.114979_bib19","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.cell.2013.11.029","article-title":"Collective invasion in breast cancer requires a conserved basal epithelial program","volume":"155","author":"Cheung","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2024.114979_bib20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/dvdy.24476","article-title":"Retinoic acid signaling regulates Krt5 and Krt14 independently of stem cell markers in submandibular salivary gland epithelium","volume":"246","author":"Abashev","year":"2017","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.celrep.2024.114979_bib21","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.devcel.2019.04.010","article-title":"Epithelial-Mesenchymal Plasticity in Cancer Progression and Metastasis","volume":"49","author":"Lu","year":"2019","journal-title":"Dev. Cell"},{"key":"10.1016\/j.celrep.2024.114979_bib22","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.1073\/pnas.1424795112","article-title":"CD14-expressing cancer cells establish the inflammatory and proliferative tumor microenvironment in bladder cancer","volume":"112","author":"Cheah","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2024.114979_bib23","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrm2720","article-title":"Collective cell migration in morphogenesis, regeneration and cancer","volume":"10","author":"Friedl","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.celrep.2024.114979_bib24","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s13046-021-02086-3","article-title":"Chemoresistance is mediated by ovarian cancer leader cells in\u00a0vitro","volume":"40","author":"Karimnia","year":"2021","journal-title":"J.\u00a0Exp. Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2024.114979_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11010032","article-title":"Non-Invasive Fluorescent Monitoring of Ovarian Cancer in an Immunocompetent Mouse Model","volume":"11","author":"Wilson","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.celrep.2024.114979_bib26","article-title":"Disrupting ovarian cancer metastatic colonization: insights from metastasis suppressor studies","volume":"2010","author":"Khan","year":"2010","journal-title":"J.\u00a0Oncol."},{"key":"10.1016\/j.celrep.2024.114979_bib27","article-title":"Targeting Myeloid-Derived Suppressor Cells in Ovarian Cancer","volume":"10","author":"Mabuchi","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.celrep.2024.114979_bib28","article-title":"Understanding the impact of chemotherapy on the immune landscape of high-grade serous ovarian cancer","volume":"39","author":"Vanguri","year":"2022","journal-title":"Gynecol. Oncol. Rep."},{"key":"10.1016\/j.celrep.2024.114979_bib29","doi-asserted-by":"crossref","first-page":"10045","DOI":"10.1002\/cam4.5590","article-title":"Peripheral and tumor-infiltrating immune cells are correlated with patient outcomes in ovarian cancer","volume":"12","author":"Zhang","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.celrep.2024.114979_bib30","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/cei.13044","article-title":"Ovarian cancer stem cells promote tumour immune privilege and invasion via CCL5 and regulatory T\u00a0cells","volume":"191","author":"You","year":"2018","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.celrep.2024.114979_bib31","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3727\/096504015X14343704124430","article-title":"CXCL12-CXCR4 Axis Promotes Proliferation, Migration, Invasion, and Metastasis of Ovarian Cancer","volume":"22","author":"Guo","year":"2014","journal-title":"Oncol. Res."},{"key":"10.1016\/j.celrep.2024.114979_bib32","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40425-019-0511-6","article-title":"Cancer-cell-secreted CXCL11 promoted CD8+ T\u00a0cells infiltration through docetaxel-induced-release of HMGB1 in NSCLC","volume":"7","author":"Gao","year":"2019","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.celrep.2024.114979_bib33","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/mc.22916","article-title":"CXCR7 is not obligatory for CXCL12-CXCR4-induced epithelial-mesenchymal transition in human ovarian cancer","volume":"58","author":"Zheng","year":"2019","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.celrep.2024.114979_bib34","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1002\/stem.1194","article-title":"Autocrine CCL5 signaling promotes invasion and migration of CD133+ ovarian cancer stem-like cells via NF-\u03baB-mediated MMP-9 upregulation","volume":"30","author":"Long","year":"2012","journal-title":"Stem Cell."},{"key":"10.1016\/j.celrep.2024.114979_bib35","doi-asserted-by":"crossref","first-page":"5846","DOI":"10.18632\/oncotarget.3462","article-title":"CD133+ ovarian cancer stem-like cells promote non-stem cancer cell metastasis via CCL5 induced epithelial-mesenchymal transition","volume":"6","author":"Long","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.celrep.2024.114979_bib36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12943-018-0787-z","article-title":"CCL2\/CCL5 secreted by the stroma induce IL-6\/PYK2 dependent chemoresistance in ovarian cancer","volume":"17","author":"Pasquier","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.celrep.2024.114979_bib37","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1165\/rcmb.2013-0142OC","article-title":"Proteinase-activated receptor-1, CCL2, and CCL7 regulate acute neutrophilic lung inflammation","volume":"50","author":"Mercer","year":"2014","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.celrep.2024.114979_bib38","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/carcin\/21.4.585","article-title":"Development of a syngeneic mouse model for events related to ovarian cancer","volume":"21","author":"Roby","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.celrep.2024.114979_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13030487","article-title":"DPP4 Inhibitor Sitagliptin Enhances Lymphocyte Recruitment and Prolongs Survival in a Syngeneic Ovarian Cancer Mouse Model","volume":"13","author":"Wilson","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.celrep.2024.114979_bib40","article-title":"Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis","volume":"18","author":"O'Sullivan","year":"2020","journal-title":"J.\u00a0Vis. Exp."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124724013305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124724013305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:43:42Z","timestamp":1773236622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124724013305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2211124724013305"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2024.114979","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Leader cells promote immunosuppression to drive ovarian cancer progression in\u00a0vivo","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2024.114979","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"114979"}}